Biotage AB (publ) (BIOT.ST)
SEK 90.55
(-0.11%)
SEK 90.55
(-0.11%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.27 Billion SEK | 81.48% |
| 2022 | 702 Million SEK | 13.23% |
| 2021 | 620 Million SEK | 39.51% |
| 2020 | 444.4 Million SEK | -3.43% |
| 2019 | 460.18 Million SEK | 52.87% |
| 2018 | 301.02 Million SEK | 102.59% |
| 2017 | 148.59 Million SEK | 12.6% |
| 2016 | 131.95 Million SEK | 8.01% |
| 2015 | 122.17 Million SEK | 5.0% |
| 2014 | 116.36 Million SEK | 0.77% |
| 2013 | 115.47 Million SEK | -6.3% |
| 2012 | 123.24 Million SEK | -8.81% |
| 2011 | 135.15 Million SEK | 7.71% |
| 2010 | 125.47 Million SEK | -9.31% |
| 2009 | 138.36 Million SEK | -20.58% |
| 2008 | 174.21 Million SEK | -9.42% |
| 2007 | 192.33 Million SEK | -6.08% |
| 2006 | 204.79 Million SEK | -13.4% |
| 2005 | 236.48 Million SEK | 37.47% |
| 2004 | 172.02 Million SEK | -20.78% |
| 2003 | 217.15 Million SEK | 250.96% |
| 2002 | 61.87 Million SEK | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.05 Billion SEK | -16.14% |
| 2024 Q1 | 1.25 Billion SEK | -1.26% |
| 2024 Q3 | 1.05 Billion SEK | 0.0% |
| 2023 Q3 | 1.31 Billion SEK | 4.46% |
| 2023 FY | 1.27 Billion SEK | 81.48% |
| 2023 Q4 | 1.27 Billion SEK | -2.9% |
| 2023 Q2 | 1.25 Billion SEK | 86.35% |
| 2023 Q1 | 674 Million SEK | -3.99% |
| 2022 Q3 | 707 Million SEK | 4.43% |
| 2022 Q4 | 702 Million SEK | -0.71% |
| 2022 Q1 | 601 Million SEK | -3.06% |
| 2022 FY | 702 Million SEK | 13.23% |
| 2022 Q2 | 677 Million SEK | 12.65% |
| 2021 Q3 | 414 Million SEK | 6.12% |
| 2021 FY | 620 Million SEK | 39.51% |
| 2021 Q1 | 493.49 Million SEK | 11.05% |
| 2021 Q2 | 390.11 Million SEK | -20.95% |
| 2021 Q4 | 620 Million SEK | 49.76% |
| 2020 Q3 | 431.23 Million SEK | 1.64% |
| 2020 Q2 | 424.26 Million SEK | -9.66% |
| 2020 FY | 444.4 Million SEK | -3.43% |
| 2020 Q1 | 469.64 Million SEK | 2.06% |
| 2020 Q4 | 444.4 Million SEK | 3.05% |
| 2019 Q2 | 495.98 Million SEK | 8.39% |
| 2019 FY | 460.18 Million SEK | 52.87% |
| 2019 Q4 | 460.18 Million SEK | -3.05% |
| 2019 Q1 | 457.58 Million SEK | 52.01% |
| 2019 Q3 | 474.64 Million SEK | -4.3% |
| 2018 Q1 | 282.22 Million SEK | 89.93% |
| 2018 Q4 | 301.02 Million SEK | 6.59% |
| 2018 FY | 301.02 Million SEK | 102.59% |
| 2018 Q3 | 282.4 Million SEK | -0.22% |
| 2018 Q2 | 283.03 Million SEK | 0.29% |
| 2017 Q1 | 129.18 Million SEK | -2.1% |
| 2017 Q4 | 148.59 Million SEK | 14.36% |
| 2017 Q3 | 129.93 Million SEK | 1.71% |
| 2017 FY | 148.59 Million SEK | 12.6% |
| 2017 Q2 | 127.75 Million SEK | -1.11% |
| 2016 Q4 | 131.95 Million SEK | 11.16% |
| 2016 Q2 | 123.34 Million SEK | 2.23% |
| 2016 Q1 | 120.65 Million SEK | -1.24% |
| 2016 FY | 131.95 Million SEK | 8.01% |
| 2016 Q3 | 118.71 Million SEK | -3.75% |
| 2015 Q4 | 122.17 Million SEK | -1.09% |
| 2015 FY | 122.17 Million SEK | 5.0% |
| 2015 Q1 | 121.98 Million SEK | 4.84% |
| 2015 Q3 | 123.52 Million SEK | 2.79% |
| 2015 Q2 | 120.16 Million SEK | -1.49% |
| 2014 Q1 | 124.09 Million SEK | 7.46% |
| 2014 Q2 | 121.87 Million SEK | -1.79% |
| 2014 Q4 | 116.36 Million SEK | -5.3% |
| 2014 FY | 116.36 Million SEK | 0.77% |
| 2014 Q3 | 122.87 Million SEK | 0.82% |
| 2013 Q2 | 122.63 Million SEK | 0.96% |
| 2013 Q3 | 108.76 Million SEK | -11.31% |
| 2013 FY | 115.47 Million SEK | -6.3% |
| 2013 Q4 | 115.47 Million SEK | 6.17% |
| 2013 Q1 | 121.46 Million SEK | -1.44% |
| 2012 Q4 | 123.24 Million SEK | 0.08% |
| 2012 Q1 | 132.92 Million SEK | -1.65% |
| 2012 Q2 | 127.41 Million SEK | -4.15% |
| 2012 FY | 123.24 Million SEK | -8.81% |
| 2012 Q3 | 123.15 Million SEK | -3.34% |
| 2011 Q2 | 121.26 Million SEK | -1.19% |
| 2011 FY | 135.15 Million SEK | 7.71% |
| 2011 Q3 | 126.37 Million SEK | 4.21% |
| 2011 Q4 | 135.15 Million SEK | 6.95% |
| 2011 Q1 | 122.72 Million SEK | -2.2% |
| 2010 Q4 | 125.47 Million SEK | -0.91% |
| 2010 Q3 | 126.63 Million SEK | -3.06% |
| 2010 Q2 | 130.62 Million SEK | 45.54% |
| 2010 FY | 125.47 Million SEK | -9.31% |
| 2010 Q1 | 89.75 Million SEK | -35.13% |
| 2009 Q4 | 138.36 Million SEK | 0.0% |
| 2009 FY | 138.36 Million SEK | -20.58% |
| 2008 FY | 174.21 Million SEK | -9.42% |
| 2007 FY | 192.33 Million SEK | -6.08% |
| 2006 FY | 204.79 Million SEK | -13.4% |
| 2005 FY | 236.48 Million SEK | 37.47% |
| 2004 FY | 172.02 Million SEK | -20.78% |
| 2003 FY | 217.15 Million SEK | 250.96% |
| 2002 FY | 61.87 Million SEK | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AddLife AB (publ) | 7.78 Billion SEK | 83.635% |
| Bonesupport Holding AB (publ) | 143.63 Million SEK | -786.946% |
| Doxa AB (publ) | 280.8 Million SEK | -353.704% |
| Elekta AB (publ) | 21.61 Billion SEK | 94.107% |
| iZafe Group AB (publ) | 9.26 Million SEK | -13656.614% |
| Ortivus AB (publ) | 55.4 Million SEK | -2199.597% |
| Ortivus AB (publ) | 55.4 Million SEK | -2199.597% |
| Q-linea AB (publ) | 42.34 Million SEK | -2908.975% |
| S2Medical AB (publ) | 19.74 Million SEK | -6350.812% |
| Synsam AB (publ) | 5.52 Billion SEK | 76.924% |